CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Alimera Sciences, Inc. - ALIM CFD

    2.57
    1.98%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.28
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    关键数据
    前收盘价* 2.52
    开仓* 2.52
    1 年变化* -54.84%
    日范围* 2.5 - 2.66
    52 周范围 1.30-7.92
    平均交易量（10 天） 3.75M
    平均交易量（3 个月) 12.93M
    市值 19.33M
    市盈率 -100.00K
    流通股 7.40M
    收入 55.78M
    EPS -2.44
    股息（收益率 %） N/A
    贝塔 1.39
    下一个财报发布日期 Jul 25, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    Jun 2, 2023 2.57 0.06 2.39% 2.51 2.66 2.50
    Jun 1, 2023 2.52 -0.08 -3.08% 2.60 2.60 2.51
    May 31, 2023 2.67 0.19 7.66% 2.48 2.67 2.48
    May 30, 2023 2.52 0.05 2.02% 2.47 2.55 2.47
    May 26, 2023 2.49 0.08 3.32% 2.41 2.52 2.35
    May 25, 2023 2.48 -0.02 -0.80% 2.50 2.51 2.37
    May 24, 2023 2.41 0.23 10.55% 2.18 2.42 2.14
    May 23, 2023 2.32 -0.19 -7.57% 2.51 2.55 2.21
    May 22, 2023 2.45 0.28 12.90% 2.17 2.72 2.15
    May 19, 2023 2.23 0.12 5.69% 2.11 2.30 2.02
    May 18, 2023 2.34 -0.26 -10.00% 2.60 3.05 2.26
    May 17, 2023 1.93 0.11 6.04% 1.82 1.94 1.78
    May 16, 2023 1.79 0.21 13.29% 1.58 1.92 1.58
    May 15, 2023 1.57 -0.03 -1.88% 1.60 1.68 1.56
    May 12, 2023 1.56 -0.05 -3.11% 1.61 1.64 1.55
    May 11, 2023 1.57 0.02 1.29% 1.55 1.64 1.48
    May 10, 2023 1.52 -0.11 -6.75% 1.63 1.85 1.51
    May 9, 2023 1.63 -0.14 -7.91% 1.77 1.77 1.63
    May 8, 2023 1.73 -0.06 -3.35% 1.79 1.80 1.73
    May 5, 2023 1.83 -0.05 -2.66% 1.88 2.04 1.76

    Alimera Sciences, Inc. Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Wednesday, July 12, 2023

    时间（协调世界时） (UTC)

    13:30

    国家/地区

    US

    事件

    Alimera Sciences Inc Annual Shareholders Meeting
    Alimera Sciences Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Tuesday, July 25, 2023

    时间（协调世界时） (UTC)

    12:30

    国家/地区

    US

    事件

    Q2 2023 Alimera Sciences Inc Earnings Release
    Q2 2023 Alimera Sciences Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 13, 2023

    时间（协调世界时） (UTC)

    13:30

    国家/地区

    US

    事件

    Q3 2023 Alimera Sciences Inc Earnings Release
    Q3 2023 Alimera Sciences Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 54.129 59.029 50.82 53.943 46.599
    收入 54.129 59.029 50.82 53.943 46.599
    收入成本，共计 7.977 7.03 6.941 6.626 4.308
    毛利 46.152 51.999 43.879 47.317 42.291
    总营业费用 65.769 57.438 51.321 59.217 58.035
    销售/一般/行政费用，总计 38.858 35.843 32.036 38.958 38.042
    研究与开发 16.228 13.778 9.668 10.992 11.274
    Depreciation / Amortization 2.706 2.579 2.676 2.641 2.645
    异常费用（收入） 0 -1.792 0 1.766
    营业收入 -11.64 1.591 -0.501 -5.274 -11.436
    利息收入（费用），非经营净值 -5.789 -4.997 -4.906 -4.953 -4.84
    税前净收入 -18.079 -3.934 -5.407 -10.227 -16.276
    税后净收入 -18.107 -4.372 -5.339 -10.443 -16.382
    未计算非常项目前的净收益 -18.107 -4.372 -5.339 -10.443 -16.382
    净收入 -18.107 -4.372 -5.339 -10.443 -16.382
    普通股股东可获收益 (不含非经常性项目) -18.107 -4.372 -5.339 -10.443 21.948
    普通股股东可获收益 (含非經常性項目) -18.107 -4.372 -5.339 -10.443 21.948
    摊薄净收入 -18.107 -4.372 -5.339 -10.443 21.948
    摊薄后加权平均股 6.99685 6.59524 5.11766 4.7702 5.91587
    扣除特别项目的每股摊薄盈利 -2.58788 -0.6629 -1.04325 -2.18921 3.71002
    每股正常摊薄盈利 -2.58788 -0.83951 -1.04325 -2.18921 3.90406
    Other Operating Expenses, Total
    非常规项目总计 0 0
    Total Adjustments to Net Income 0 38.33
    其他，净值 -0.65 -0.528
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 13.546 14.029 13.598 14.604 11.898
    收入 13.546 14.029 13.598 14.604 11.898
    收入成本，共计 2.028 2.125 2.006 2.166 1.68
    毛利 11.518 11.904 11.592 12.438 10.218
    总营业费用 16.848 16.137 17.009 16.578 16.045
    销售/一般/行政费用，总计 9.975 9.099 9.856 9.81 10.093
    研究与开发 4.164 4.23 4.483 3.932 3.583
    Depreciation / Amortization 0.681 0.683 0.664 0.67 0.689
    营业收入 -3.302 -2.108 -3.411 -1.974 -4.147
    利息收入（费用），非经营净值 -1.68 -1.621 -1.567 -1.345 -1.256
    税前净收入 -4.968 -3.781 -5.245 -3.098 -5.955
    税后净收入 -4.968 -3.78 -5.257 -3.115 -5.955
    未计算非常项目前的净收益 -4.968 -3.78 -5.257 -3.115 -5.955
    净收入 -4.968 -3.78 -5.257 -3.115 -5.955
    普通股股东可获收益 (不含非经常性项目) -4.982 -3.78 -5.257 -3.115 -5.955
    普通股股东可获收益 (含非經常性項目) -4.982 -3.78 -5.257 -3.115 -5.955
    摊薄净收入 -4.982 -3.78 -5.257 -3.115 -5.955
    摊薄后加权平均股 7.03223 7.00032 6.99658 6.99971 6.99074
    扣除特别项目的每股摊薄盈利 -0.70845 -0.53998 -0.75137 -0.44502 -0.85184
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 -0.70845 -0.53998 -0.75137 -0.44502 -0.85184
    异常费用（收入） 0 0 0
    其他，净值 0.014 -0.052 -0.267 0.221 -0.552
    Total Adjustments to Net Income -0.014
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 29.413 42.16 34.906 32.745 34.848
    现金和短期投资 5.274 16.51 11.208 9.426 13.043
    现金等价物 5.274 16.51 11.208 9.426 13.043
    应收账款总额，净额 19.612 19.128 17.2 19.331 17.259
    Accounts Receivable - Trade, Net 19.612 19.128 17.2 19.331 17.259
    Total Inventory 1.605 2.679 2.746 1.39 2.405
    Prepaid Expenses 2.892 3.809 3.718 2.565 2.109
    Other Current Assets, Total 0.03 0.034 0.034 0.033 0.032
    Total Assets 42.602 58.52 50.855 50.309 54.108
    Property/Plant/Equipment, Total - Net 3.92 4.493 2.358 2.047 1.355
    Property/Plant/Equipment, Total - Gross 7.981 7.923 6.305 5.858 4.967
    Accumulated Depreciation, Total -4.061 -3.43 -3.947 -3.881 -3.612
    Intangibles, Net 8.957 10.897 12.838 14.783 16.723
    Other Long Term Assets, Total 0.129 0.137 0.753 0.734 1.182
    Total Current Liabilities 39.732 12.592 12.348 12.048 10.234
    Accounts Payable 10.088 8.706 7.461 7.077 6.355
    Accrued Expenses 3.998 3.617 3.197 4.716 3.643
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 25.646 0.269 1.69 0.255 0.236
    Other Current Liabilities, Total
    Total Liabilities 63.41 61.125 58.833 54.754 51.386
    Total Long Term Debt 18.683 43.08 42.922 38.752 38.178
    Long Term Debt 18.683 43.08 42.408 38.658 37.873
    Capital Lease Obligations 0.514 0.094 0.305
    Other Liabilities, Total 4.995 5.453 3.563 3.954 2.974
    Total Equity -20.808 -2.605 -7.978 -4.445 2.722
    Preferred Stock - Non Redeemable, Net 19.227 19.227 19.227 30.344 30.344
    Common Stock 0.07 0.069 0.057 0.05 0.701
    Additional Paid-In Capital 378.238 377.229 365.83 350.117 346.108
    Retained Earnings (Accumulated Deficit) -415.388 -397.281 -392.539 -383.863 -373.42
    Other Equity, Total -2.955 -1.849 -0.553 -1.093 -1.011
    Total Liabilities & Shareholders’ Equity 42.602 58.52 50.855 50.309 54.108
    Total Common Shares Outstanding 6.99551 6.93515 5.71937 4.96595 4.67193
    Total Preferred Shares Outstanding 0.6 0.6 0.6 0.61015 0.61015
    Long Term Investments 0.183 0.833
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 35.675 29.413 29.76 33.073 34.753
    现金和短期投资 13.086 5.274 5.514 7.859 9.946
    现金等价物 13.086 5.274 5.514 7.859 9.946
    应收账款总额，净额 18.433 19.612 19.142 20.319 18.776
    Accounts Receivable - Trade, Net 18.433 19.612 19.142 20.319 18.776
    Total Inventory 1.215 1.605 1.786 1.656 2.452
    Prepaid Expenses 2.91 2.892 3.29 3.208 3.546
    Other Current Assets, Total 0.031 0.03 0.028 0.031 0.033
    Total Assets 48.239 42.602 43.429 47.574 49.931
    Property/Plant/Equipment, Total - Net 3.757 3.92 3.87 3.938 4.343
    Intangibles, Net 8.479 8.957 9.446 9.935 10.419
    Other Long Term Assets, Total 0.131 0.129 0.118 0.126 0.134
    Total Current Liabilities 14.173 39.732 34.01 25.431 17.006
    Accounts Payable 9.669 10.088 8.706 7.614 6.604
    Accrued Expenses 4.241 3.998 3.661 3.316 3.046
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0.263 25.646 21.643 14.501 7.356
    Total Liabilities 67.155 63.41 61.507 59.909 58.534
    Total Long Term Debt 44.312 18.683 22.492 29.297 36.245
    Long Term Debt 44.152 18.683 22.492 29.297 36.245
    Capital Lease Obligations 0.16
    Other Liabilities, Total 8.67 4.995 5.005 5.181 5.283
    Total Equity -18.916 -20.808 -18.078 -12.335 -8.603
    Preferred Stock - Non Redeemable, Net 7.728 19.227 19.227 19.227 19.227
    Common Stock 0.074 0.07 0.07 0.07 0.07
    Additional Paid-In Capital 378.146 378.238 378.005 377.847 377.541
    Retained Earnings (Accumulated Deficit) -402.081 -415.388 -411.608 -406.351 -403.236
    Other Equity, Total -2.783 -2.955 -3.772 -3.128 -2.205
    Total Liabilities & Shareholders’ Equity 48.239 42.602 43.429 47.574 49.931
    Total Common Shares Outstanding 7.39159 6.99551 6.99802 6.99546 6.99265
    Total Preferred Shares Outstanding 0.012 0.6 0.6 0.6 0.6
    Long Term Investments 0.197 0.183 0.235 0.502 0.282
    Other Current Liabilities, Total
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -18.107 -4.372 -5.339 -10.443 -16.382
    经营活动产生的现金 -9.975 -3.224 -2.193 -4.152 -11.553
    经营活动产生的现金 2.706 2.579 2.676 2.641 2.645
    Deferred Taxes 0.116 0.61 0.031 0.454 -0.653
    非现金物品 2.621 -0.692 1.829 3.377 7.084
    Cash Taxes Paid 0.232 0.112 0.11 0.239 0.239
    已付现金利息 4.489 4.302 4.556 4.419 3.571
    营运资金的变化 2.689 -1.349 -1.39 -0.181 -4.247
    投资活动产生的现金 -0.255 -0.621 -0.62 -0.174 -0.175
    资本支出 -0.255 -0.621 -0.62 -0.174 -0.175
    融资活动产生的现金 -0.302 9.823 3.882 0.869 0.95
    融资现金流项目 -0.113 0 -0.019 -2.227 -3.808
    股票的发行（报废），净额 0.1 10.044 0.049 0.902 0.085
    债务的发行（退还），净额 -0.289 -0.221 3.852 2.194 4.673
    外汇效应 -0.708 -0.676 0.714 -0.159 -0.248
    现金净变化 -11.24 5.302 1.783 -3.616 -11.026
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -4.968 -18.107 -14.327 -9.07 -5.955
    Cash From Operating Activities -2.209 -9.975 -9.724 -7.811 -6.213
    Cash From Operating Activities 0.681 2.706 2.023 1.359 0.689
    Non-Cash Items 0.507 2.621 2.095 1.318 1.027
    Cash Taxes Paid 0 0.232 0.224 0.182 0.018
    Cash Interest Paid 1.354 4.489 3.253 2.145 1.061
    Changes in Working Capital 1.571 2.689 0.485 -1.418 -1.974
    Cash From Investing Activities -0.009 -0.255 -0.171 -0.041 -0.149
    Capital Expenditures -0.009 -0.255 -0.171 -0.041 -0.149
    Cash From Financing Activities 9.998 -0.302 -0.109 -0.164 -0.062
    Financing Cash Flow Items -3.123 -0.113
    Issuance (Retirement) of Debt, Net 2.373 -0.289 -0.164 -0.204 -0.062
    Foreign Exchange Effects 0.033 -0.708 -0.998 -0.638 -0.141
    Net Change in Cash 7.813 -11.24 -11.002 -8.654 -6.565
    Issuance (Retirement) of Stock, Net 10.748 0.1 0.055 0.04
    Deferred Taxes 0.116
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Velan Capital Investment Management LP Investment Advisor/Hedge Fund 22.4131 1659654 1401901 2023-05-17 MED
    Ocumension Therapeutics Corporation 15.4621 1144945 0 2023-04-24 LOW
    Morgan Stanley & Co. LLC Research Firm 8.9243 660832 0 2023-03-31 MED
    Caligan Partners, LP Hedge Fund 6.4657 478777 0 2023-05-17 MED
    Eiswirth (Richard S Jr) Individual Investor 4.3555 322518 500 2023-04-24 LOW
    HOOPP Investment Management Pension Fund 3.3762 250000 0 2023-03-31 HIGH
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.0071 148624 0 2023-03-31 LOW
    Ashman Philip Individual Investor 1.8004 133315 0 2023-04-24 MED
    Holland (David R) Individual Investor 1.4704 108880 500 2023-04-24 LOW
    Renaissance Technologies LLC Hedge Fund 1.3693 101394 -1100 2023-03-31 HIGH
    Skibsted (Russell L) Individual Investor 1.0196 75500 58000 2023-03-26 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5167 38262 0 2023-03-31 LOW
    Jones (John Philip) Individual Investor 0.4347 32186 372 2022-10-31
    Millennium Management LLC Hedge Fund 0.3884 28762 16799 2023-03-31 HIGH
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.2639 19542 0 2023-03-31 MED
    Bridgeway Capital Management, LLC Investment Advisor 0.2471 18300 0 2023-03-31 LOW
    Perritt Capital Management, Inc. Investment Advisor 0.2431 18000 0 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.175 12962 438 2023-03-31 LOW
    J.P. Morgan Securities LLC Research Firm 0.14 10364 9838 2023-03-31 MED
    Snisarenko (John) Individual Investor 0.135 10000 0 2023-04-24 LOW

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    535K+

    交易者

    87K+

    每月活跃客户

    $113M+

    每月投资额

    $64M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    Alimera Sciences, Inc. Company profile

    关于 Alimera Sciences Inc.

    Alimera Sciences, Inc.是一家制药公司。 该公司从事处方眼科药品的商业化和开发。 它专注于影响眼底或视网膜的疾病。 公司的商业产品ILUVIEN是一种玻璃体内植入物，通过在眼内持续提供微剂量的非专利皮质类固醇氟西诺龙（FAc）来治疗患者，疗程长达36个月。 该公司正致力于开发治疗糖尿病黄斑水肿（DME）的药物。 DME是一种影响糖尿病患者的视网膜疾病，可导致严重的视力丧失和失明。 ILUVIEN也可用于预防影响眼睛后段的复发性非感染性葡萄膜炎（NIU-PS）的复发。 公司直接在美国、德国、英国、葡萄牙和爱尔兰进行ILUVIEN的商业销售。

    Industry: Biopharmaceuticals

    Ste 290
    6120 Windward Parkway
    ALPHARETTA
    GEORGIA 30005
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    XRP/USD

    0.52 Price
    -1.220% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00332

    US100

    14,557.80 Price
    +0.640% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 3.0

    Gold

    1,948.36 Price
    -1.480% 1D Chg, %
    多头隔夜费 -0.0185%
    空头隔夜费 0.0103%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    BTC/USD

    27,087.75 Price
    -0.480% 1D Chg, %
    多头隔夜费 -0.0616%
    空头隔夜费 0.0137%
    隔夜费时间 21:00 (UTC)
    价差 60.00

    还在找一位您可以信任的经纪商吗？

    加入成为全球535,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易